N-SMase Antibodies

Santa Cruz Biotechnology features a diverse variety of N-SMase monoclonal antibodies for advanced research in cell signaling and lipid metabolism. N-SMase Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). N-SMase, or neutral sphingomyelinase, plays a critical role in the hydrolysis of sphingomyelin to generate ceramide, a key lipid mediator involved in numerous cellular processes such as apoptosis, cell growth, and inflammation. Understanding the function of N-SMase is essential for elucidating its contributions to various diseases, including cancer and neurodegenerative disorders. The study of N-SMase and its pathways can provide insights into potential therapeutic targets and strategies. Research focused on N-SMase has revealed its significance in cellular stress responses and membrane organization. N-SMase activity has been linked to the regulation of exosome formation and intercellular communication. Investigating N-SMase mechanisms has enhanced our understanding of lipid-mediated signaling pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of sphingolipid metabolism and its impact on human health.